Andrea Goren - 18 May 2023 Form 4 Insider Report for INVO Bioscience, Inc. (IVF)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INVO	Stock option (right to buy)	Award	$0	+81,000		$0.000000	81,000	18 May 2023	Common Stock	81,000	$0.3680	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests in twelve equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested.